Lakewood, CO, September 20, 2022 (GLOBE NEWSWIRE) — KRTL Holding Group, Inc. (OTC: KRTL), an innovator and pioneer in the development of cross-business know-how and cutting-edge proprietary technology and methodology in the hemp, cannabis, psilocybin and alternative wellness industries, is pleased to announce that its wholly owned subsidiary, KRTL Biotech (“KRTL”) advanced the strategic alliance with ENTEX Corporation (“ENTEXS”), a Made in the UNITED STATES Industry-leading cannabis and hemp extraction technology manufacturer focusing on advanced end-to-end solutions and creating best-in-class THC Sanitation Technology. KRTL will join ENTEXS at MJBizCon Las Vegas in November 2022 to unveil the final design of their mobile extraction unit. There will be a live demonstration showing conference attendees a glimpse of the proprietary closed-loop technology in action with details regarding the production and operation of the ENTEX MINI 9 extraction system, a slightly smaller version of the system for use in the mobile extraction laboratory.

“MJBizCon has become an industry staple, anyone will be there, and we have top notch floor space to show off what our ENTEXS mining technology can do. KRTL joining us to demonstrate their plans for mobile extraction deployment strategy and what they are doing in the psilocybin space regarding planned formulation is an exciting prospect and something we are excited to be a part of,” said declared Emile BayanCOO of ENTEXS.

As a member of KRTL and ENTEXS alliance, the mobile mining lab isn’t the only thing to be discussed at MJBizCon. KRTL will unveil some of its formulated psilocybin products slated to launch in the newly legalized Oregon psilocybin market, which is expected to start in early 2023. The KRTL-ENTEXS strategic alliance signed earlier in the month has been amplified and accelerated because ENTEXS has already been conducting R&D on psilocybin extraction and have made their work available KRTL with exclusive technology customized and optimized for the extraction of psilocybin. This feature will be rolled out with the KRTL mobile extraction lab as it goes live, creating a complete solution supporting THC, CBD (among other cannabinoids) and now psilocybin.

“This is a great opportunity for us to show and tell what we are doing, not just the progress of the work put in KRTL so far this year, but the tremendous momentum that has been building over the past few months as others join in and add their skills, expertise and intellectual property to the mission of KRTL. ENTEXS tailors this bill to a T, quickly integrating its expertise and leveraging its own R&D and intellectual property for this mission so that everyone at the table wins. We’re excited to see where this is going and MJBizCon is the perfect stage to celebrate some of these early successful accomplishments,” said Daniel BallCEO of KRTL.

Closely related to these developments is the work KRTL made in South Korea under the Zone without hemp regulations; have been approved as a Foreign Advisor and have psilocybin research approval from the MFDS, KRTL International keep pushing KRTL priorities. They will introduce critical technologies as part of the KRTL-ENTEXS alliance, such as THC Remediation. Remediation specifically targets THC, providing a mechanism to reduce or eliminate THC while retaining CBD and most other broad-spectrum cannabinoids in the finished distillate. Remediation allows manufacturers to make products of different concentrations of CBD without the psychoactive side effects. It is important to note that product dilution is not remediation. ENTEXS’ exclusive RMD-T series achieves industry-leading THC remediation benchmarks with cost-effective technology, boasts a CBD loss rate of less than 5%, has a USDA-certified organic catalyst, and is scalable alongside business operations. Competitive alternatives see wastage rates 3-10 times that amount or cannot scale with any cost-effectiveness. This dilution effect is not an issue with the RMD-T series, capable of even remedying mother liquor to non-detection with low loss rates. This technology will enhance KRTL leadership in South Korea and alleviate regulatory concerns for other producers in the Zone without hemp regulations as the final legal framework is finalized for the rest of the country in the months and years to come.

Kai Kim CEO of KRTL International added: “We are very pleased with this partnership. First, we can advance our trial ambitions. Second, we can seize a lucrative THC opportunity in United States with a mobile lab and we introduce timely disruptive remediation technology in South Korea.

About KRTL Holding Group, Inc.
KRTL is a holding company interested in diversifying risk and accessing new markets. The Company operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.with precision and excellence and continues to create and strengthen the KRTL reputation. this allows KRTL Holding Group, Inc. to capitalize on any range of investment opportunities. Our organization values ​​collaboration and emphasizes a transparent work environment.

Additional information on KRTL is available online at and, and

About ENTEX Corporation
ENTEX provides top-notch customer service with extraction technology designed and manufactured in-house to constantly evolve and develop machines for the needs of the hemp and cannabis markets. Addressing the bottlenecks of the typical extraction process, their patent-pending technology is hands-free, continuous, and closed-loop, with no winterizing or rotovaping required. This breakthrough increases the productivity, yields and quality of each extraction on a high-capacity industrial scale. Compliant with global standards such as cGMP, EUGMP and UI, all ENTEXS systems are customized to unique operational specifications.

For more information, log on to (888) 960-ENTX or [email protected].

KRTL Holding Group, Inc.

14143 Denver W Pkwy #100
Lakewood, CO 80401

Email: [email protected]
Main: 800-707-0586
IR: 855-464-2535 Ext. 1

main logo

Source: KRTL Holding Group

2022 GlobeNewswire, Inc., source Press Releases

Comments are closed.